Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies
2022Future Journal of Pharmaceutical SciencesJournalOpen access
10.1186/s43094-022-00409-5Full text3 citations